Condition
Plasma Volume
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07190924Not ApplicableCompleted
Inflammatory Responses After CrossFit and Resistance Trainings in Untrained Subjects
NCT07118462Phase 4Recruiting
HighCycle Study: Acetazolamide, High Altitude and Plasma Volume
NCT03963089Not ApplicableCompletedPrimary
Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children
NCT03422809CompletedPrimary
Cyclic Variation in Micronutrient Concentrations and Plasma Volume
NCT01483781Phase 1Completed
A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus
Showing all 5 trials